Viking Therapeutics Inc.
VKTX
|
|
| |
|
| Trading Volume | 60,314 |
|
|
94.50 - 9.24 |
| Market Cap Full | $ 5.1B |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 6.7% | 339.5% | 77.1% | -34.8% |
| Q2 | - | -36% | -2.6% | -3.7% |
| Q3 | - | 1.3% | -31.7% | -5.9% |
| Q4 | - | -20.1% | 71.2% | 245.6% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.7 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 29.7 | 219.2 | 6.2 | -21.2 | -3.4 | -18.1 | - | - | - | - | - | - |
| 2023 | |||||||||||
| -6.8 | 25.7 | 51.2 | 28 | 3.1 | -26.2 | -10.6 | -4.8 | -19.8 | -11.4 | 24.6 | 52.3 |
| 2022 | |||||||||||
| -19.4 | -9.4 | -10.7 | -20.7 | -6.7 | 30.2 | 4.2 | 5.7 | -14.5 | 50.7 | -1.2 | 132.1 |
| 2021 | |||||||||||
| 26.3 | -7.4 | -6.6 | 1 | -17.5 | 13.7 | 2.7 | 7.5 | -5 | -7.3 | -8.8 | -13.4 |
| 2020 | |||||||||||
| -23.6 | -3.4 | -21.3 | 23.1 | 24.1 | 0.8 | -2.6 | -4.7 | -13 | -3.3 | 13.6 | -9.5 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.3 | -0.2 | -0.2 | -0.1 |
| Q2 | -0.2 | -0.2 | -0.2 | -0.1 |
| Q3 | -0.2 | -0.2 | -0.2 | -0.1 |
| Q4 | 0 | -0.3 | -0.2 | -0.2 |
| A | -0.67 | -0.9 | -0.7 | -0.5 |